Omnitrope (Somatropin) 6.7mg Sandoz *vial 1.5ML


Manufacturer : Sandoz 

Basic substance : Somatropin 

package : 1 Cardridge 6.7mg *1.5 ml

Category :HGH 


Omnitrope HGH is a recombinant [somatropin rDNA origin] , mainly prescribed to children with growth failure due to growth hormone deficiency (GHD) and elderly patients for anti-aging purposes.



Omnitrope (Somatropin) 6.7mg Sandoz *vial 1.5ML

OMNITROPE 6.7mg/1.5ML is used to stimulate growth in small children / adolescents with growth hormone secretion deficiency (growth hormone deficiency) or delayed intrauterine development of body length , growth disorders due to chronic renal failure, Prader-Willi syndrome in combination with low-calorie diet, as well as in girls with Turner syndrome. In adults, treatment with OMNITROPE 6.7mg/1.5ML may also be initiated as part of a marked growth hormone deficiency resulting from growth hormone (hypothalamus and pituitary gland) -treated gland disease, or to continue treatment. growth hormone deficiency seen in childhood. Before initiating treatment with Omnitrope, the doctor will confirm growth hormone deficiency, chronic renal failure, Prader-Willi syndrome or Turner’s syndrome with a thorough review. Only a specialist doctor can order treatment during growth problems. In the same way, the continuation of a treatment will be only under the control of a specialist doctor.

What should be considered outside treatment?
In small children / adolescents, this medecine will only act on body growth if the growth phase is not over.

Teenagers practicing a competitive sport should be aware that the active ingredient of Omnitrope can give a positive result in a doping control.

When should OMNITROPE 6.7mg/1.5ML not be used?
Certain conditions (such as an active tumor) or treatments (eg anticancer) may cause the doctor not to prescribe Omnitrope. He will also not use this medecine to treat certain critically ill patients with complications after surgery or serious injury, as well as those with certain (rare) congenital diseases (such as Down syndrome, Bloom syndrome, or Fanconi anemia). ) or highly diabetic patients.


Uses and dosage :

The dosage and administration schedule should be appropriate for each patient.

Growth retardation due to growth hormone secretion deficiency in pediatric patients
In general, the recommended dosage is 0.025 to 0.035 mg / kg of body weight per day or 0.7 to 1.0 mg / m2 of body surface area per day. Higher doses were used.


Side effects:

GH can cause several side effects, which are disturbing. The most common include:

Generalized edema
Carpal tunnel syndrome
Joint and muscle pain
Neuropathies (e.g., numbness and tingling)
Increase blood glucose levels



There are no reviews yet.

Be the first to review “Omnitrope (Somatropin) 6.7mg Sandoz *vial 1.5ML”

Select your currency
USD United States (US) dollar
EUR Euro